CoChat

Glucagon‐like peptide‐1 reduces hepatic glucose production indirectly through insulin and glucagon in humans

LARSSON, H., HOLST, J. J., AHRÉN, B. · 1997 · Acta Physiologica Scandinavica
Cited by 114

The DOI matches its Crossref record.

Abstract

The effect of glucagon‐like peptide‐1 (GLP‐1) on hepatic glucose production and peripheral glucose utilization was investigated with or without infusion of somatostatin to inhibit insulin and glucagon secretion in 13 healthy, non‐diabetic women aged 59 years. After 120 min 3‐3 H‐glucose infusion, GLP‐1 was added (4.5 pmol kg−1 bolus + 1.5 pmol kg−1 min−1). Without somatostatin (n = 6), GLP‐1 decreased plasma glucose (from 4.8 ± 0.2 to 4.2 ± 0.3 mmol L−1, P = 0.007). Insulin levels were increased (48 ± 3 vs. 243 ± 67 pmol L−1, P = 0.032), as was the insulin to glucagon ratio (P = 0.044). The rate of glucose appearance (Ra) was decreased (P = 0.003) and the metabolic clearance rate of glucose (MCR) was increased during the GLP‐1 infusion (P = 0.024 vs. saline). Also, the rate of glucose disappearance (Rd) was reduced during the GLP‐1 infusion (P = 0.004). Since Ra was reduced more than Rd, the net glucose flow was negative, which reduced plasma glucose. Somatostatin infusion (500 μ g h−1, n = 7) abolished the effects of GLP‐1 on plasma glucose, serum insulin, insulin to glucagon ratio, Ra, Rd, MCR and net glucose flow. The results suggest that GLP‐1 reduces plasma glucose levels mainly by reducing hepatic glucose production and increasing the metabolic clearance rate of glucose through indirectly increasing the insulin to glucagon ratio in healthy subjects.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-201x.1997.00161.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 114

Metadata

Authors
LARSSON, H., HOLST, J. J., & AHRÉN, B.
Venue
Acta Physiologica Scandinavica
Publisher
Wiley
Published
1997-07
Volume
160
Issue
4
Pages
413-422
ISSN
  • 0001-6772 (ISSN-L)
  • 1365-201X
OpenAlex
W2048998821
Cited by
114
References
0
FWCI
0.88
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucagon‐like peptide‐1 reduces hepatic glucose production indirectly through insulin and glucagon in humans. https://app.cochat.ai/papers/10.1046/j.1365-201x.1997.00161.x
The paper
LARSSON, H., HOLST, J. J., & AHRÉN, B. (1997). Glucagon‐like peptide‐1 reduces hepatic glucose production indirectly through insulin and glucagon in humans. Acta Physiologica Scandinavica. https://doi.org/10.1046/j.1365-201x.1997.00161.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.